Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation
Yaheng Wu Jingtao Liu Wei Zhao Huachong Ma Guo An Jia Tong Wenlong Zhang Zhihua Tian Bin Dong Xijuan Liu Lin Zhao Chunxiang Ye
基因与疾病(英文)2025,Vol.12Issue(5):414-429,16.
基因与疾病(英文)2025,Vol.12Issue(5):414-429,16.DOI:10.1016/j.gendis.2025.101702
Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation
Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation
摘要
关键词
CCL2/Galectin-3/Gemcitabine/Pancreaticstellate cells/Pancreatic adenocarcinomaKey words
CCL2/Galectin-3/Gemcitabine/Pancreaticstellate cells/Pancreatic adenocarcinoma引用本文复制引用
Yaheng Wu,Jingtao Liu,Wei Zhao,Huachong Ma,Guo An,Jia Tong,Wenlong Zhang,Zhihua Tian,Bin Dong,Xijuan Liu,Lin Zhao,Chunxiang Ye..Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation[J].基因与疾病(英文),2025,12(5):414-429,16.基金项目
This study was funded by the Noncommunicable Chronic Diseases-National Science and Technology Major Project(China)(No.2024ZD0520200),the National Natural Science Foundation of China(No.81802353),the Foundation of China Association for Promotion of Health Science and Technology(No.JKHY2024003),the Science Foundation of Peking University Cancer Hospital(China)(No.A003004),and the Research Enhancement Fund of Shandong Provin-cial Hospital(China)(No.2024TS12). (China)